Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Orgenesis Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 22 | −1 |
| Shares | 2.82M | 2.22M | −602.2K (−21.3%) |
| Value | $3.93M | $1.37M | −$2.55M (−65.0%) |
New holders (3)
Institutions that held Orgenesis Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prudential Financial Inc | 19,000 | $11.5K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 18,330 | $11.0K | 0.00% |
| Qube Research & Technologies Ltd | 1 | $1 | 0.00% |
Sold out (4)
Institutions that held Orgenesis Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Redmond Asset Management, LLC | 579,980 | $806.2K |
| Dimensional Fund Advisors LP | 16,541 | $23.0K |
| Eqis Capital Management, Inc. | 12,529 | $17.4K |
| Tower Research Capital LLC (TRC) | 2,156 | $3.00K |